Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Management of postirradiation sepsis.

Brook I, Elliott TB, Ledney GD, Knudson GB.

Mil Med. 2002 Feb;167(2 Suppl):105-6. Review.

PMID:
11873487
2.

Management of postirradiation infection: lessons learned from animal models.

Brook I, Elliott TB, Ledney GD, Shoemaker MO, Knudson GB.

Mil Med. 2004 Mar;169(3):194-7. Review.

PMID:
15080238
3.

Quinolone therapy in the management of infection after irradiation.

Brook I, Ledney GD.

Crit Rev Microbiol. 1992;18(4):235-46. Review.

PMID:
1524673
4.

Imipenem/Cilastatin : A Reappraisal of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Efficacy.

Buckley MM, Brogden RN, Barradell LB, Goa KL.

Drugs. 1992 Sep;44(3):408-444. doi: 10.2165/00003495-199244030-00008.

PMID:
28634918
5.
6.

[The history of the development and changes of quinolone antibacterial agents].

Takahashi H, Hayakawa I, Akimoto T.

Yakushigaku Zasshi. 2003;38(2):161-79. Japanese.

PMID:
15143768
7.
8.

Use of selective decontamination in the prevention of infection after accidental irradiation. A review.

Brook I, Ledney GD.

Prehosp Disaster Med. 1993 Jan-Mar;8(1):85-8. Review.

PMID:
10155457
9.

Quinolone therapy in the prevention of mortality after irradiation.

Brook I, Elliott TB.

Radiat Res. 1991 Oct;128(1):100-3.

PMID:
1924719
10.

Antibiotic use in neonatal sepsis.

Yurdakök M.

Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Review.

PMID:
9722468
11.

Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia.

Marra A, Lamb L, Medina I, George D, Gibson G, Hardink J, Rugg J, Van Deusen J, O'Donnell JP.

Antimicrob Agents Chemother. 2012 Sep;56(9):4671-5. doi: 10.1128/AAC.00276-12. Epub 2012 Jun 18.

12.

Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.

Elliott TB, Bolduc DL, Ledney GD, Kiang JG, Fatanmi OO, Wise SY, Romaine PL, Newman VL, Singh VK.

Int J Radiat Biol. 2015;91(9):690-702. doi: 10.3109/09553002.2015.1054526. Epub 2015 Jun 8.

13.

Quinolone therapy in the prevention of endogenous and exogenous infection after irradiation.

Brook I, Ledney GD.

J Antimicrob Chemother. 1994 Apr;33(4):777-84.

PMID:
8056696
14.
15.
16.

Comparative chemotherapeutic activity of new fluorinated 4-quinolones and standard agents against a variety of bacteria in a mouse infection model.

Sesnie JC, Fritsch PW, Griffin TJ, Heifetz CL, Leopold ET, Malta TE, Shapiro MA, Vincent PW.

J Antimicrob Chemother. 1989 May;23(5):729-36.

PMID:
2759922
18.

In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.

Sedlock DM, Dobson RA, Deuel DM, Lesher GY, Rake JB.

Antimicrob Agents Chemother. 1990 Apr;34(4):568-75.

19.

Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.

Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H.

Molecules. 2016 Jan 6;21(1):62. doi: 10.3390/molecules21010062.

20.

Therapy of infections in mice irradiated in mixed neutron/photon fields and inflicted with wound trauma: a review of current work.

Ledney GD, Madonna GS, Elliott TB, Moore MM, Jackson WE 3rd.

Radiat Res. 1991 Oct;128(1 Suppl):S18-28. Review.

PMID:
1924743

Supplemental Content

Support Center